On Invalid Date, Addex Therapeutics (NASDAQ: ADXN) reported Q1 2023 earnings per share (EPS) of -$0.04, up 73.01% year over year. Total Addex Therapeutics earnings for the quarter were -$2.65 million. In the same quarter last year, Addex Therapeutics's earnings per share (EPS) was -$0.16.
As of Q2 2023, Addex Therapeutics's earnings has grown year over year. Addex Therapeutics's earnings in the past year totalled -$19.54 million.
What was ADXN's revenue last quarter?
On Invalid Date, Addex Therapeutics (NASDAQ: ADXN) reported Q1 2023 revenue of $550.43 thousand up 113.46% year over year. In the same quarter last year, Addex Therapeutics's revenue was $257.87 thousand.
What was ADXN's revenue growth in the past year?
As of Q2 2023, Addex Therapeutics's revenue has grown -26.19% year over year. This is 95.72 percentage points lower than the US Biotechnology industry revenue growth rate of 69.54%. Addex Therapeutics's revenue in the past year totalled $1.89 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.